Global Biological Skin Substitutes Market Overview 2023-2028
The global biological skin substitutes market size reached US$ 302 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 481 Million by 2028, exhibiting a growth rate (CAGR) of 7.9% during 2023-2028
Biological skin substitutes represent cutting-edge medical solutions for wound care and tissue regeneration. These innovative products are either sourced from human or animal tissues or produced using bioengineered materials. Customizable to fit each patient’s wound size and shape, they offer viable alternatives to conventional skin grafts. These substitutes are instrumental in facilitating efficient wound healing, lowering the chances of infection and complications. Moreover, they contribute to more visually appealing results with minimal scarring. Their capacity to shorten hospital stays and expedite recovery times has fueled a growing global demand for biological skin substitutes.
Global Biological Skin Substitutes Market Trends and Drivers:
The market’s growth is driven by several key factors. Firstly, the rising incidence of chronic wounds and age-related conditions, such as diabetic ulcers, in the geriatric population plays a significant role. Additionally, vascular diseases are contributing to an increased demand for wound care solutions. Biological skin substitutes have emerged as a promising solution to enhance the healing process for patients dealing with chronic wounds. Furthermore, these substitutes are instrumental in reducing the overall cost of wound care by expediting healing and minimizing complications, resulting in shorter hospital stays and reduced medical interventions. Another notable trend is the growing patient proactivity in healthcare decision-making. Patients are increasingly seeking treatments that not only promote better quality of life but also minimize discomfort. Biological skin substitutes align perfectly with this trend, offering less painful and aesthetically pleasing wound healing experiences. Advancements in tissue engineering and regenerative medicine are continuously shaping the landscape of biological skin substitutes. These innovations lead to the development of more sophisticated products with improved efficacy, ultimately delivering better outcomes for patients. Simultaneously, increased awareness among healthcare professionals and patients, driven by educational initiatives and research findings, is contributing to the market’s favorable outlook. This, coupled with the expanding global demand for advanced wound care solutions, provides a positive market trajectory.
Global Biological Skin Substitutes Market 2023-2028 Analysis and Segmentation:
Top Key Players covered in this report are:
Integra LifeSciences, Mallinckrodt Pharmaceuticals, MIMEDX Group Inc., Organogenesis Holdings Inc., Smith & Nephew PLC, Stryker Corporation, Tissue Regenix Group. Vericel Corporation, etc.
The report segmented the market on the basis of region, type, application, and end user.
Breakup by Type:
- Human Donor Tissue-derived Products
- Acellular Animal-derived Products
Breakup by Application:
- Acute Wounds
- Chronic Wounds
Breakup by End User:
- Outpatient Facilities
- Research and Manufacturing
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023- 2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Services Private Limited.
134 N 4th St. Brooklyn, NY 11249, USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800